In this Consultant Case Report Insights, Matthew Nemoy, DO, discusses his team’s study, “Supraclavicular Lymphadenopathy as the Presenting Feature of Disseminated Mycobacterium Tuberculosis,” including the...
PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.
Jeffrey R. Starke, MD, from Baylor College of Medicine, answers our questions about the management of pediatric TB, the new advancements in this area of medicine, and other takeaways that pulmonologists...
In this commentary, Eusondia Arnett, PhD, explains her research on apoptosis in Mycobacterium tuberculosis infection. It is her hope to discover how to limit and better treat tuberculosis.
In this commentary, Eusondia Arnett, PhD, explains her research on apoptosis in Mycobacterium tuberculosis infection. It is her hope to discover how to limit and better treat tuberculosis.
Dr Varun Dwivedi, from Texas Biomedical Research Institute, discusses his research on the role of IL-10 in Mycobacterium tuberculosis infection, the potential for a new MTB vaccine, and how this vaccine...
Dr Varun Dwivedi, from Texas Biomedical Research Institute, discusses his research on the role of IL-10 in Mycobacterium tuberculosis infection, the potential for a new MTB vaccine, and how this vaccine...
Dr Eusondia Arnett, from Texas Biomedical Research Institute, talks about her research on apoptosis in Mycobacterium tuberculosis infection and how cancer drugs might be able to fight the infection.
Dr Eusondia Arnett, from Texas Biomedical Research Institute, talks about her research on apoptosis in Mycobacterium tuberculosis infection and how cancer drugs might be able to fight the infection.
